This is a preview of subscription content, log in via an institution to check access.
References
Benetó, N., Vilageliu, L., Grinberg, D., & Canals, I. (2020). Sanfilippo syndrome: Molecular basis, disease models and therapeutic approaches. International Journal of Molecular Sciences, 21(21), 7819.
Kaczor-Kamińska, M., Stalińska, K., Kamiński, K., Pisarek, A., Maziarz, U., Feldman, A., & Wróbel, M. (2020). Murine cellular model of mucopolysaccharidosis, type IIIB (MPS IIIB) - A preliminary study with particular emphasis on the non-oxidative l-cysteine metabolism. Biochimie, 174, 84–94.
Khan, S. A., Peracha, H., Ballhausen, D., Wiesbauer, A., Rohrbach, M., Gautschi, M., Mason, R. W., Giugliani, R., Suzuki, Y., Orii, K. E., Orii, T., & Tomatsu, S. (2017). Epidemiology of mucopolysaccharidoses. Molecular Genetics and Metabolism, 121(3), 227–240.
Lidia, G., Pierzynowska, K., Piotrowska, E., & Wegrzyn, G. (2018). How close are we to therapies for Sanfilippo disease? Metabolic Brain Disease, 33, 1–10.
Lin, H. Y., Lo, Y. T., Wang, T. J., et al. (2019). Normalization of glycosaminoglycan-derived disaccharides detected by tandem mass spectrometry assay for the diagnosis of mucopolysaccharidosis. Science and Reports, 9, 10755.
Ozkinay, F., Emecen, D. A., Kose, M., Isik, E., Bozaci, A. E., Canda, E., Tuysuz, B., Zubarioglu, T., Atik, T., & Onay, H. (2021). Clinical and genetic features of 13 patients with mucopolysaccarhidosis type IIIB: Description of two novel NAGLU gene mutations. Molecular Genetics and Metabolism Report, 27(3), 100732.
Porter, K. A., O’Neill, C., Drake, E., Parker, S., Escolar, M. L., Montgomery, S., Moon, W., Worral, C., & Peay, H. L. (2021). Parent experiences of sanfilippo syndrome impact and unmet treatment needs: a qualitative assessment. Neurology Therapy, 10, 197–212.
Weber, B., Guo, X.-H., Kleijer, W. J., van de Kamp, J. J., Poorthuis, B. J., & Hopwood, J. J. (1999). Sanfilippo type B syndrome (mucopolysaccharidosis III B): allelic heterogeneity corresponds to the wide spectrum of clinical phenotypes. European Journal of Human Genetics, 7(1), 34–44.
Wijburg, F. A., Węgrzyn, G., Burton, B. K., & Tylki-Szymańska, A. (2013). Mucopolysaccharidosis type III (Sanfilippo syndrome) and misdiagnosis of idiopathic developmental delay, attention deficit/hyperactivity disorder or autism spectrum disorder. Acta Paediatrica, 102(5), 462–470.
Zhao, H. G., Li, H. H., Bach, G., Schmidtchen, A., & Neufeld, E. F. (1996). The molecular basis of Sanfilippo syndrome type B. Proceedings of the National Academy of Sciences of the United States of America, 93(12), 6101–6105.
Acknowledgements
The cell lines and DNA bank of Rett Syndrome, X-linked mental retardation and other genetic diseases, member of the Telethon Network of Genetic Biobanks (Project No. GTB12001), funded by Telethon Italy, and of the EuroBioBank network, provided us with specimens.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bruno, L.P., Fava, F., Baldassarri, M. et al. Identification of a Novel Pathogenic Variant in the NAGLU Gene in a Child with Neurodevelopmental Delay. J Autism Dev Disord 52, 4605–4607 (2022). https://doi.org/10.1007/s10803-021-05332-x
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10803-021-05332-x